ADH-5
Methodology
Immunohistochemistry (IHC)
Test Description and clinical significance
Disease:
Breast Cancer
ADH-5 simultaneously tests for 5 key markers (CK5/14, p63 and CK7/18) of breast disease in one simple staining procedure. This multiplex IHC product can assist with the diagnosis of a range of breast cancer indications: Invasive versus noninvasive breast lesions can be easily distinguished by the presence or absence of myoepithelium (CK5/14 and/or p63, DAB) and glandular staining of breast cancer with CK7/18 (Fast Red). ADH-5 can clearly differentiate hyperplasia of the usual type from atypical hyperplasia, and identifies microinvasion and basal phenotypes in breast cancer.
Specimen Requirements
Collection:
FFPE/un-stained slides/Fresh tissue in formalin
Stability:
Room temperature
Unacceptable Conditions:
Unlabeled specimen/specimen left unfixed
for extended periods
Storage & Transport
Room Temperature
CPT(s)
88344
New York Approved
NO
TAT
1 Day
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
